Document Detail

Human melanoma cell invasion: selected neurotrophin enhancement of invasion and heparanase activity.
MedLine Citation:
PMID:  9487024     Owner:  NLM     Status:  MEDLINE    
Heparanase is an endo-beta-D-glucuronidase whose enzymatic targets are the glycosaminoglycan chains of heparan sulfate proteoglycans. Elevated levels of heparanase are associated with the metastatic potential of melanoma cells. Treatment of murine and human melanoma cells with the prototypic neurotrophin nerve growth factor (NGF) increases the production of heparanase by melanoma cells. We previously reported that physiologic concentrations of NGF increased in vitro Matrigel invasion of early passage human brain-metastatic 70W melanoma cells but not melanoma cells metastatic to other sites or nonmetastatic melanoma cells. Here we found that treatment of 70W melanoma cells with neurotrophin-3 (NT-3) increased Matrigel invasion, whereas treatment with neurotrophins other than NGF or NT-3 did not influence invasion. Mutants of NGF that do not bind to the neurotrophin receptor p75NTR or other nonneuronal growth factors were not able to enhance the invasion of 70W melanoma cells. When 70W cells were exposed to anti-sense oligonucleotides directed against p75NTR mRNA, there was a reduction in NGF and NT-3 binding, and the neurotrophins failed to enhance Matrigel invasion. To study to properties of heparanase in NT-regulated melanoma-invasive processes, we developed a sensitive heparanase assay consisting of purified [35S]heparan sulfate subpopulations separated by agarose gel electrophoresis. Incubation of 70W cells with NGF or NT-3, but not BDNF, NT-4/5, or mutant NGF, resulted in increased release of heparanase activity that was capable of degrading a subpopulation of heparan sulfate molecules.
D Marchetti; G L Nicolson
Related Documents :
17982274 - Catecholamine production along the nephron.
17122314 - Electrophysiological differences between neurogliaform cells from monkey and rat prefro...
7722654 - Topa quinone, a kainate-like agonist and excitotoxin is generated by a catecholaminergi...
21043034 - Paeoniflorin protects against nmda-induced neurotoxicity in pc12 cells via ca(2+) antag...
7590274 - Rat intestinal crypt-cell replication factor with homology to early s-phase proteins re...
11079404 - Odour discrimination in the olfactory bulb of goldfish: contrasting interactions betwee...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The journal of investigative dermatology. Symposium proceedings / the Society for Investigative Dermatology, Inc. [and] European Society for Dermatological Research     Volume:  2     ISSN:  1087-0024     ISO Abbreviation:  J. Investig. Dermatol. Symp. Proc.     Publication Date:  1997 Aug 
Date Detail:
Created Date:  1998-03-10     Completed Date:  1998-03-10     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9609059     Medline TA:  J Investig Dermatol Symp Proc     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  99-105     Citation Subset:  IM    
Department of Tumor Biology, University of Texas M. D. Anderson Cancer Center, Houston 77030, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Biocompatible Materials
Brain Neoplasms / metabolism,  pathology*
Drug Combinations
Glycoside Hydrolases / metabolism*
Melanoma / metabolism,  pathology*
Neoplasm Invasiveness
Nerve Growth Factors / metabolism,  pharmacology*
Oligonucleotides, Antisense / pharmacology
Receptors, Nerve Growth Factor / metabolism
Tumor Cells, Cultured
Grant Support
Reg. No./Substance:
0/Biocompatible Materials; 0/Drug Combinations; 0/Laminin; 0/Nerve Growth Factors; 0/Oligonucleotides, Antisense; 0/Proteoglycans; 0/Receptors, Nerve Growth Factor; 119978-18-6/matrigel; 9007-34-5/Collagen; EC 3.2.1.-/Glycoside Hydrolases; EC 3.2.1.-/heparanase; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Melanocortin receptors, red hair, and skin cancer.
Next Document:  The regulation of cell volume: the mechanisms of intracellular signalling